• Linkedin
  • Twitter
  • Facebook
  • Instagram
  • youtube
Войти / Регистрация
+995 595 38 00 38
HTI Centers
  • Linkedin
  • Twitter
  • Facebook
  • Instagram
  • youtube
+995 595 38 00 38
Войти / Регистрация
  • Second Opinion
    • Что мы предлагаем
    • Как это работает
    • Часто задаваемые вопросы
  • News
    • Covid News
    • Новости Грузии
    • Зарубежные новости
    • Полезные советы
  • О нас
    • Медицинский туризм в Грузии
    • Связаться с нами
  • Партнеры
    • Клиники
    • Оздоровительные спа-центры
    • Туристические Компании
    • Врачи
    • Отели
  • Предложения
  • Услуги
    • Общая медицина
      • Хирургия
      • Онкология
      • Ангиохирургия
      • Кардиохирургия
      • Больше ...
    • Стоматология
      • Больше ...
    • Эстетическая медицина
      • пересадка волос
      • коррекция груди
      • пластика носа
      • коррекция веса
      • Больше ...
    • Реабилитация
      • физиотерапевтические процедуры
      • вытяжение позвоночника
      • пелоидотерапия (аппликации лечебной грязью)
      • гидромассаж
      • минеральная ванна
    • СПА и оздоровительные процедуры
      • сауна
      • массаж
      • бассейн
      • ванны
      • баня
    • Конференции и образовательные программы
      • EANS – European Association of Neurosurgical Societies
      • RSNA – Radiological Society of North America
      • ECR – European Congress of Radiology
      • ESS – European Society of Surgery
      • WCS – World Congress of Surgery
    • Технология
      • Магнитно Резонансная Томография
      • Рентген
      • Компьютерная Томография
      • Ультразвуковое исследование
    • Отдых
      • О Грузии
      • Путешествие по Грузии
      • Путешествие за рубежом
      • Туры по Грузии
      • Туры за рубеж

Врачи

Главная
/
Врачи
/
Озлем Эр
Озлем Эр
рабочее место: Группа клиник «Acibadem»

профессия: ,

Разговорный язык:

выбрать переводчик:

выберите доступную дату

забронировать онлайн-консультацию
loading...

Озлем Эр

Ассоциированный профессор онкологии и внутренней медицины

Дата и место рождения: 1970г. Измир, Турция

Место работы: Больница «Аджибадем» в Маслаке, департамент онкологии

Академическая степень: Ассоциированный профессор онкологии и внутренней медицины в больнице «Аджибадем» в Маслаке.

Квалификация:

1994г. доктор, медицинский факультет университета Гаджетепе, Анкара, Турция

1999г. специалист по внутренней медицине, больница Нуми в Анкаре, Турция

2002г.специалист медицинской онкологии, университет Эрче, Турция

2003-2004гг. доктор, центр рака Андерсона, медицинская онкология груди, США

2006-2008гг. AVON-AACR сотрудник биологии рака, университет Тома Джеферсона, США

Академические интересы: твердые опухоли – раки груди, колоректальный рак, рак легкого – целевая терапия, тромбоз у больных раком.

Исследования/проекты: Принято участие в нескольких национальных и международных мульти центральных клинических исследованиях.

Опыт, принятый за рубежом: центр рака доктора Андерсона, отделение медицинской онкологии, 2003г. октябрь-2004г. март (клинический наблюдатель Габриэль Н. Хортобаг)

Университет Тома Джеферсона, Филадельфия, Пенсильвания

2006-2008гг. AVON-AACR сотрудник биологии рака.

Членство:

Ассоциированный член ASCO

Действительный член ESMO (подтвержденный)

Член онкологической группы Турции AACR

Получено до 10 наград и опубликовано до 100 публикаций.

Awards: 29th ESMO Travel Award (Vienna, 2004)

Clinical Course Of Breast Cancer Patients With Liver Metastases Only

Treated With Chemotherapy. Ozlem Er , Debbie Frye, Kristine Broglio,

Vicente Valero, Gabriel N. Hortobagyi, Banu Arun.

Journal of Thrombosis and Haemostasis 2004 Young Investigator

Prize

A Randomized Clinical Trial Of Combination Chemotherapy With And

Without Low Molecular Weight Heparin In Small Cell Lung Cancer.

Mustafa Altinbas, Hasan Senol Coskun, Ozlem Er, Metin Ozkan, Bulent

Eser, Ali Unal, Mustafa Cetin, Serdar Soyuer.

Avon Foundation-American Association for Cancer Research

International Scholars Award in Breast Cancer Research (2006)

Role of Caveolin in breast cancer pathogenesis

2

Publications A. Papers Published in Peer-Reviewed Journals:

 

A1. Mustafa Cetin, Yusuf Ozkul, Ali Unal, Bulent Eser, Omer Ozturk,

Recep Kutlubay, Ozlem Er, Hatice Burakgazi. The effect of

medroxyprogesterone acetate on bone marrow and testis during

cytotoxic chemotherapy. Cell Biology and Toxicology, 16, 385-390

(2000);

A2. Mustafa Cetin, Bulent Eser, Ozlem Er, Ali Unal, Mehmet Bilgin.

Extreme thrombocytosis after penetrating femoral venous injury.

Hematology, 6, 69-72 (2001);

A3. Bulent Eser, Mustafa Cetin, Olgun Kontas, Ali Unal, Ozlem Er,

Hasan S Coskun, Mustafa Altınbas. Facial nerve paralysis and paraplagia

as presenting symptoms of acute leukemia. Japan J Clin Oncol 31(2),

86-88 (2001);

A4. Ozlem Er, H.Senol Coskun, Mustafa Altınbas, Hulya Akgun,

Mustafa Cetin, Bulent Eser, Al i Unal. Rapidly relapsing squamous

cell carcinoma of renal pelvis associated with paraneoplastic syndromes

of leukocytosis, thrombocytosis and hypercalcemia. Urologia

Internationalis 67,175-177 (2001);

A5. Mustafa Cetin, Bulent Eser, Ozlem Er, Ali Unal, Eser Kılıc, Tahir

Patıroğlu, Hasan S Coskun, Mustafa Altınbas, Onder Arslan, Osman

İlhan. Effects of DMSO on platelet functions and P-Selectin expression

during storage. Transfusion and Apheresis Science 24, 261-267 (2001);

A6. Isın Soyuer, Serdar Soyuer, Ozlem Canoz, Ozlem Er, Yucel Arıtas.

Correspondence. Cytopathology 13 (3), 177 (2002);

A7. Berna Oksuzoğlu, Ozlem Er, Mehmet Guler,Mutlu Doğanay, Mustafa

Esen, Nuri Aydın Kama. Disseminated high grade malignant lymphoma

involving both of the breasts. The Breast 11:454-456 (2002);

A8. Mustafa Altınbas, Ozlem Er, Metin Ozkan,Hasan S Coskun, İnci

Gulmez, Eyup Ekici, Bunyamin Kaplan, Bulent Eser, Mustafa Ozesmi.

Ifosfamide, mesna and interferon alfa combination

chemoimmunotherapy in malignant mesothelioma:results of a single

center in Central Anatolia. Medical Oncology 21(4):359-366 (2004);

A9. Bunyamin Kaplan, Mustafa Altınbas, Celalettin Eroğlu, Eray

Karahacıoğlu, Ozlem Er, Metin Ozkan, Mehmet Bilgin, Ozlem Canoz, İnci

Gulmez, Mustafa Gulec. Preliminary results of a phase II study of

weekly paclitaxel (PTX) and carboplatin (CBDCA) administered

concurrently with thoracic radiation therapy (TRT) followed by

consolidation chemotherapy with PTX/CBDCA for stage III unresectable

non-small cell lung cancer (NSCLC). American Journal of Clinical

Oncology 27 (6):603-610 (2004);

A10. Metin Ozkan, Mustafa Altinbas, Ozlem Er, Bunyamin Kaplan,

Hasan Senol Coskun, Eray Karahacioğlu, Ahmet Menku, Yasemin Cihan,

Olgun Kontas, Hidayet Akdemir. Post-operative sequential chemoradiotherapy

in high-grade cerebral gliomas with fotemustine. Journal of

Chemotherapy 16 (3):298-302 (2004);

A11. Metin Ozkan, Ozlem Er, Bunyamin Kaplan, Mustafa Altinbas,

Bulent Ozcelik, Fatma Tokat, Edip Torun, Okkes Ibrahim Karahan;

3

Presentation with superior vena cava syndrome secondary to solitary

lung metastasis mimicking primary lung cancer following resection of a

uterine malignant mixed mullerian tumor. Eur J Obs Gyn & Rep Biol 118

(2): 260-264 (2005);

A12. M Ozkan, B Eser, Ozlem Er, F Altuntas, R Coskun, R Topsakal, E

Mavili, M Kala, M Altinbas. Antiphospholipid syndrome associated with

malignant mesothelioma presenting with superior vena cava thrombosis:

A case report. Clin Appl Throm Hemos 10 (4): 393-396 (2004);

A13. Mustafa Altinbas, Hasan S. Coskun, Ozlem Er, Metin Ozkan,

Bulent Eser, Ali Unal, Mustafa Cetin, Serdar Soyuer. A randomized

clinical trial of combination chemotherapy with and without low

molecular weight heparin in small cell lung cancer. J Throm Hemostasis

2 (8): 1266-1271 (2004);

A14. Ozlem Er, Hasan S. Coskun, Mustafa Altinbas, Metin Ozkan,

Bulent Eser, Mustafa Cetin, Fevzi Altuntas, Ali Unal. Meropenem +/-

granulocyte colony stimulating factor in the treatment of febrile

neutropenic patients with cancer: Prospective randomized study.

Journal of Chemotherapy 16 (3):288-292 (2004);

A15. Bulent Eser, Fevzi Altuntas, Ozlem Er, Olgun Kontas, Ayten

Ferahbas, Mustafa Cetin, Ali Unal. A case of subcutaneous panniculitis

like T-cell lymphoma with hemophagocytosis secondary to

chemotherapy. JEADV 18 (6):713-715 (2004);

A16. Gulmez I, Kart L, Buyukoglan H, Er O, Balkanli S, Ozesmi M.

Evaluation of malignant mesothelioma in central Anatolia: a study of 67

cases. Can Respir J 11(4):287-90 (2004);

A17. Mustafa Altinbas, Ozlem Er, Metin Ozkan, Yusuf Solak, H. Senol

Coskun, Can Kucuk, Sebnem Gursoy. Irinotecan Plus Cisplatin

Combination Against Metastatic Gastric Cancer: Phase II Study. Medical

Oncology 2005; 22(2):153-60;

A18. Hasan Senol Coskun, Ozlem Er, Serdar Soyuer, Mustafa Altınbas,

Bulent Eser,Eray Karahacioglu, Fevzi Altuntas. Solitary Plasmacytoma:

Experiences From Central Anatolia. Irish J Med Sci 2005 Jan-

Mar;174(1):33-6;

A19. O. Er, M. Ozkan, M. Altinbas, H.S. Coskun, B. Eser, F. Altuntas, M.

Cetin, A. Unal. “Outpatient 5-fluorouracil+a-interferon+interleukin-2

chemoimmunotherapy in metastatic renal cell cancer patients” Asia-

Pacific J Clin Oncol, 1, 145-150 (2005);

A20. Dogu GG, Ozkan M, Er O, Eser B, Altinbas M. Squamous cell

carcinoma of colorectal cancer: adjuvant radiotherapy is necessary? Eur

J Cancer Care (Engl). 2005 Dec;14(5):465;

A21. M. Ozkan, B. Eser, O. Er, H. S. Coskun, A. Ozturk, I. Sari, O.

Canoz, M. Altinbas. “Bone marrow involvement in small cell lung cancer:

Prognostıc significance and correlation with hematological and

biochemical parameters” Asia–Pacific J Clin Oncol, 2, 32–38 (2006);

A22. B Eser, B Kaplan, A Unal, O Canoz, F Altuntas, HI Sari, Ozlem Er,

Metin Ozkan, Can Kucuk, Makbule Arar, Sebnem Gursoy, and Mustafa

Cetin. Clinicopathologic Characteristics and Therapeutic Outcomes Of

Primary Gastrointestinal Non-Hodgkin’s Lymphomas in Central Anatolia,

4

in Turkey. Yonsei Medical Journal 2006 Feb 28;47 (1):22-33;

A23. Eser B, Sari I, Canoz O, Altuntas F, Cakmak E, Ozturk A, Ozkan M,

Er O, Cetin M, Unal A. Prognostic significance of Fas (CD95/APO-1)

positivity in patients with primary nodal diffuse large B-cell lymphoma.

Am J Hematol. 2006 May;81(5):307-14;

A24. Bulent Eser, Fevzi Altuntas, Işın Soyuer, Ozlem Er, Ozlem Canoz,

Hasan S Coskun, Mustafa Cetin, Ali Unal. Acute Lymphoblastic Leukemia

Associated with Brucellosis in Two Patients with Fever and Pancytopenia.

Yonsei Medical Journal 2006; 47(5): 741-744;

A25. Nihat Kalay, Emrullah Basar, Ibrahim Ozdogru, Ozlem Er, Yakup

Cetinkaya, Ali Dogan, Tugrul Inanc, Abdurrahman Oguzhan, Namik

Kemal Eryol, Ramazan Topsakal, Ali Ergin. Protective effects of carvedilol

against anthracycline-induced cardiomyopathy. J Am Coll Cardiol. 2006

Dec 5;48(11):2258-62;

A26. Ozlem Canoz, Metın Ozkan, Vedat Arsav, Ozlem Er, HS Coskun, S

Soyuer, M Altinbas. The role of c-erbB-2 expression on the survival of

patients with small-cell lung cancer. Lung 2006; 184(5):267-272;

A27. Ozlem Er, Leo R Zacharski. Management of cancer-associated

thrombosis. Vascular Health and Risk Management 2006; 2(4):351-356;

A28. M Sofikerim, I Gulmez, F Tokat, Ozlem Er, I Gulmez. Epidermoid

carcinoma of the lung with isolated penile metastasis. Can J Urol. 2007

Aug;14(4):3643-5;

A29. Yaman E, Uner A, Er O, Coskun U, Buyukberber S, Dikilitas M,

Polat M, Yamac D, Kaya AO, Yildiz R, Ozturk B, Benekli M. Capecitabine

plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients

with metastatic colorectal cancer. Med Oncol. 2007;24(4):431-5;

A30 Benekli M, Yildiz R, Uner A, Er O, Yamac D, Alkis N, Coskun

U,Camci C, Buyukberber S. Gemcitabine plus Capecitabine Combination

in Metastatic Breast Cancer Patients Previously Treated with

Anthracyclines and Taxanes. Oncology. 2007;72(5-6):308-313;

A31 O Er, DK Frye, SC Kau, K Broglio, V Valero, GN Hortobagyi, B

Arun. Clinical Course of Breast Cancer Patients with Metastases

Limited to the Liver Treated with Chemotherapy. Cancer J 2008;

14(1):62-68;

A32. Coskun U, Buyukberber S, Yaman E, Uner A, Er O, Ozkan M,

Dikilitas M, Oguz M, Yildiz R, B DY, Kaya AO, Benekli M. Xelox

(capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of

unresectable liver metastases in colorectal cancer patients. Neoplasma

2008;55(1):65-70;

A33. O Er, S Mistik, M Ozkan, A Ozturk, M Altinbas. Factors related to

complementary/alternative medicine use among cancer patients in

Central Anatolia. Tumori 2008; 94: 833-837;

A34. Dogu GG, Ozkan M, Ozturk F, Dikilitas M, Er O, Ozturk A. Triplenegative

breast cancer: immunohistochemical correlation with basaloid

markers and prognostic value of survivin. Med Oncol. 2009 Jan 21;

5

A35. Sotgia F, Casimiro MC, Bonuccelli G, Liu M, Whitaker-Menezes D,

Er O, Daumer KM, Mercier I, Witkiewicz AK, Minetti C, Capozza F,

Gormley M, Quong AA, Rui H, Frank PG, Milliman JN, Knudsen ES, Zhou

J, Wang C, Pestell RG, Lisanti MP. Loss of caveolin-3 induces a lactogenic

microenvironment that is protective against mammary tumor formation.

Am J Pathol. 2009 Feb;174(2):613-29;

A36. Karaoglu A, Arslan UY, Ozkan M, Kalender ME, Alici S, Coskun U,

Gumus M, Celenkoglu G, Er O, Sevinc A, Buyukberber S, Alkis N, Benekli

M. Efficacy and toxicity of gemcitabine and pegylated liposomal

doxorubicin in recurrent platinum-resistant/refractory epithelial ovarian

cancer. Asian Pac J Cancer Prev 2009 Jan-Mar; 10 (1): 63-66;

A37. Coskun U, Alkis N, Celenkoglu G, Buyukberber S, Ozkan M, Camci

C, Uner A, Er O, Aslan UY, Sevinc A, Tokluoglu S, Ozturk B, Yildiz R,

Benekli M; Anatolian Society of Medical Oncology. Gemcitabine combined

with uracil-tegafur in patients with advanced pancreatic cancer. J Natl

Med Assoc. 2009 Aug;101(8):761-764;

A38. Er O. Cancer stem cells in solid tumors. Onkologie. 2009

Oct;32(10):605-609;

A39. Karaca H, Lale A, Dikilitas M, Ozkan M, Er O. Recovery of

paraneoplastic hypercalcemia by sunitinib treatment for renal cell

carcinoma: a case report and review of the literature. Med Oncol. 2009

Oct 15;

A40. Hasan Senol COSKUN, Mustafa ALTINBAS, Ozlem ER, Figen

OZTURK, Hatice KARAMAN, Serdar SOYUER, Metin OZKAN, Isin SOYUER.

Human epidermal growth factor receptor 2 oncoprotein expression in

breast cancer patients from central Anatolia, Turkey. Asia Pacific Journal

of Clinical Oncology 2009;5:209-211;

 

B. Oral and Poster Presentations at International Meetings:

 

B1. H. S. Coskun, B. Eser, M. Cetin, A.Unal, M. Altınbas, O. Er, E.

Karahacıoğlu, B. Kaplan. Hodgkin Disease: results of single center in

Central Anatolia of Turkey. American Society of Clinical Oncology. Thirtysixth

Annual Meeting May 20-23, 2000-New Orleans, LA, USA;

B2. Ozlem Er, H.Senol Coskun, Mustafa Altınbas, Bulent Eser, Muzaffer

Keklik, Mustafa Cetin, Eray Karahacıoğlu, Ali Unal. Efficacy of vinorelbine

and doxorubicine combination chemotherapy in metastatic breast

cancer. European School of Oncology 2nd Milan Breast Cancer Congress

June 14-16, 2000,Milan, Italy;

B3. A Unal, M Cetin, B Eser, S Gucer, M Tayyar, O Er, HS Coskun.

Activated protein C resistance in Turkish women with pre-eclampsia. 5th

Annual Meeting of the European Haematology Association, p:500, 25-28

June 2000, Birmingham, UK;

B4. H. Senol Coskun, Ozlem Er, Mustafa Altınbas, Fatih Tanrıverdi,

Bulent Eser, Ali Unal, Mustafa Cetin. Adjuvant treatment of locally

advanced gastric cancer. A retrospective analysis. 25th European

Society for Medical Oncology Congress, 13-17 October 2000, Hamburg,

Germany. Annals of Oncology 2000, 11(Suppl 4): p117;

B5. Ali Unal, Bulent Eser, Mustafa Cetin, Mustafa Altınbas, Eray

6

Karahacıoğlu, Olgun Kontas, Bunyamin Kaplan, Ozlem Er, Senol

Coskun. Clinico-pathologic characteristics of non-Hodgkins lymphoma

patients at single center in Central Anatolia. 25th European Society for

Medical Oncology Congress, 13-17 October 2000, Hamburg Germany.

Annals of Oncology 2000, 11(Suppl 4): 102;

B6. M Altınbas, HS Coskun, O. Er, M Ozkan, B Eser, A Unal, M Cetin.

Prospective randomized study of epirubicine cyclophosphamide and

vincristine combination chemotherapy (CEV) + low molecular weight

heparin (LMWH) in small cell lung cancer. Proceedings of ASCO VOL 20

2001; 321a;

B7. Ozlem Er, HS Coskun, M.Altınbas, B.Eser, M.Cetin, A.Unal.

Epidemiological characteristics and results of adjuvant treatment of

colorectal cancer patients from Erciyes University Oncology Hospital in

Turkey. Proceedings of ASCO vol 20 2001;114b;

B8. Ozlem Er, HS Coskun, M.Altınbas, İ.Gulmez, B.Eser, M.Cetin,

A.Unal. Cisplatin and etoposide versus cisplatin and vinorelbine:A

retrospective comparison in patients with advanced nonsmall cell lung

cancer. International Symposium Lung Cancer and Bronchoscopy 29

Aug-1Sep 2001;

B9. M.Altınbas, O. Er, HS Coskun, S.Soyuer, A.Unal, E,Karahacıoğlu.

Palliative chemotherapy in inoperable or metastatic pancreatic

carcinoma. 4th International Conference on Biology, Prevention and

Treatment of Gastrointestinal Malignancies Sep 6-8,2001; 84;

B10. M.Altınbas, O. Er, HS Coskun, E.Ekici, İ.Gulmez, M.Ozesmi.

Ifosfamide, mesna and interferon alfa combination therapy in malignant

mesothelioma:results of a single center in central anatolia, Turkey.

European J Cancer 2001: vol 37 sup 6; 46-47;

B11. HS Coskun, O. Er, M.Altınbas, B.Eser, A.Unal, M.Cetin. Efficacy of

cisplatin etoposide combination in anthracycline refractory metastatic

breast cancer. The Breast Journal 2001;7(5): 43;

B12. HS Coskun, O. Er, M.Altınbas, O. Coban, M.Cetin, B.Eser.

Docetaxel and doxorubicin combination in salvage therapy of metastatic

breast cancer. The Breast Journal 2001;7(5): 43-44;

B13. Ozlem Er, HS Coskun, M.Altınbas, B.Eser, A.Unal, M.Cetin.

Paclitaxel and epirubicin combination therapy in metastatic breast cancer

patients. The Breast Journal 2001;7(5): 69;

B14. Ozlem Er, HS Coskun, I. Soyuer, M.Altınbas. Late onset of local

recurrence and distant metastases from breast cancer. The Breast

Journal 2001;7(5): 71;

B15. Ali Unal, Mustafa Cetin, Bulent Eser, Turkan Patıroğlu, Senol

Coskun, Ozlem Er, Bunyamin Kaplan, Mustafa Altınbas. Autologous

Peripheral Blood Stem Cell Transplantation In Patients with Resistant

and/or Relapsing Lymphoma: Single center experience. Blood 2001;

98(11): 400b;

B16. M. Altınbas, F.N. Aykan, M. Erkisi, E. Buyukunal, İ. Yucel, N. Gunel,

O. Er, N, Uskent, H. Akbulut, R. Disci, H. Camlıca, D. Fırat. Alternating

combination of irinotecan with 5-fluorpuracil and folinic acid in first line

chemotherapy of metastatic colorectal cancer (a Turkish Oncology Group

7

study). American Society of Clinical Oncology. Thirty-Eighth Annual

Meeting May 18-21, 2002 Orlonda FL, USA Prog Proceedings of ASCO

Vol: 21, 2002 Abstract: 22269;

B17. Ozlem Er, Senol Coskun, Yusuf Solak, Mustafa Altınbas. Irinotecan

Plus Cisplatin Combination Against Metastatic Gastric Adenocarcinoma:

Preliminary Results of Phase II Study. American Society of Clinical

Oncology. Thirty-Eighth Annual Meeting May 18-21, 2002 Orlando FL,

USA Prog Proceedings of ASCO Vol: 21, 2002 Abstract: 2310;

B18. B.Eser, A.Unal, M. Baskol, M. Cetin, E. Cakmak, H.S. Coskun, O.

Er. Elevated transaminase levels in patients with vitamin B12 Deficiency.

7th Meeting of the European Hematology 6-9 June 2002, Italy. The

Hematology Journal 2002; 3(Supply 1): 384;

B19. A.Unal, B.Eser, O. Canoz, B. Kaplan, H.İ. Sarı, H.S. Coskun, O. Er,

M. Altınbas, M. Cetin. Clinicopathologic characteristics and prognostics

factors of primary gastrointestinal non-Hodgkin’s lymphoma. 7th Meeting

of the European Hematology 6-9 June 2002, Italy. The Hematology

Journal 2002; 3(Supply 1): 267-268;

B20. Ozlem Er, Hasan Senol Coskun, M.Altınbas, Metin Ozkan, Bulent

Eser, Mustafa Cetin, Fevzi Altuntas, Ali Unal. Meropenem +/-

granulocyte colony stimulating factor in treatment of febrile neutropenic

patients in cancer: Prospective randomized study. 27th ESMO Congress,

18-22 October, 2002: Nice, France, 5 (supp 717p):194;

B21. M.Altınbas, Ozlem Er, Hasan Senol Coskun, Metin Ozkan, Bulent

Eser, Mustafa Cetin, Fevzi Altuntas, Ali Unal. Gemcitabin and cisplatin in

the treatment of advanced or metastatic pancreatic cancer. 27th ESMO

Congress, 18-22 October, 2002: Nice, France, 5 (supp 717p):194;

B22. H.Senol Coskun, Mustafa Altınbas, Ozlem ER, Figen Ozturk, Hatice

Karaman, Serdar Soyuer, Metin Ozkan, Isın Soyuer. HER2 expression in

Turkish breast cancer patients from a single center. 27th ESMO

Congress, 18-22 October, 2002: Nice, France, 5 (supp 41p):194;

B23. Ozlem Er, Yusuf Ozkul, Mustafa Altinbas, Sebnem Gursoy, H.Senol

Coskun, Metin Ozkan, Serpil Tekin, Hilal Akalin. K-ras codon 12

mutations in colorectal cancer patients. American Society of Clinical

Oncology Annual Meeting May 31-June 3, 2003 Chicago Illinois, USA

Prog Proceedings of ASCO 2003 Vol 22 p308, no:1238;

B24. Mustafa Altinbas, Metin Ozkan, Ozlem Er, Hatice Everest, H.Senol

Coskun, Ahmet Menku, Yasemin Cihan, Bunyamin Kaplan. Adjuvant

radiotherapy and fotemustine in treatment of anaplastic astrocytoma

and glioblastoma multiforme patients. ASCO Annual Meeting May 31-

June 3, 2003 Chicago Illinois, USA Prog Proceding of ASCO 2003 Vol 22,

p:115, no:459;

B25. Bunyamin Kaplan, Mustafa Altınbas, Celalettin Eroğlu, Eray

Karahacıoğlu, Ozlem Er, Metin Ozkan, Mehmet Bilgin, Ozlem Canoz, İnci

Gulmez, Mustafa Gulec. A phase II study of weekly paclitaxel (PTX) and

carboplatin (CBDCA) with concurrent thoracic radiation therapy (TRT)

followed by consolidation chemotherapy with PTX/CBDCA for stage III

unresectable non-small cell lung cancer (NSCLC). ASCO Annual Meeting

May 31-June 3, 2003 Chicago Illinois, USA Prog Proceedings of ASCO

2003 Vol 22, p:704, no:2832;

B26. B Eser, F Altuntas, B Kaplan, O Canoz, M Ozkan, O Er, HS Coskun,

8

K Gundogan, M Cetin, A Unal. Results of first line treatment in Hodgkin’s

disease: Single center experience. 8th Annual Congress of the European

Haematology Association, 12-15 June 2003, Lyon, France, no:0355;

B27. F Altuntas, B Eser, O Canoz, O Er, M Ozkan, B Kaplan, A Sahin, M

Cetin, A Unal. Fludarabine and fludarabine based combination

chemotherapy in chronic lymphocytic leukemia/lymphoma. 8th Annual

Congress of the European Haematology Association, 12-15 June 2003,

Lyon, France, no:0623, p:190;

B28. Ozlem Er, Metin Ozkan, Mustafa Altinbas, H. Senol Coskun, Bulent

Eser, Fevzi Altuntas, Mustafa Cetin, Ali Unal. 5-fluorouracil+interferon

alfa+ interleukin-2 chemoimmunotherapy in metastatic renal cell cancer

patients. ASCO 40th Annual Meeting 2004 New Orleans, USA Prog

Proceedings of ASCO Vol 23, 2004;

B29. H.S. Coskun, O. Er, M. Ozkan, B. Eser, M. Altinbas. Adjuvant

sequential docetaxel and cyclophosphamide-doxorubicin combination in

operable breast cancer patients. Proceedings of ASCO Vol 23 2004;81;

B30. M. Altinbas, B. Kaplan, K. Ucar, M. Ozkan, E. Karahacioglu, O. Er,

C. Kucuk, I. Soyuer. ‘5-FU plus lucovorin (Mayo Regimen) for concurrent

chemoradiotherapy after surgery in patients with resectable locally

advanced gastric carcinoma: Preliminary results of a phase II study.

‘Proceeding of ASCO vol 22 2004;4196;

B31. Mustafa Altinbas, Metin Ozkan, Ozlem Er, Ramazan Coskun,

Bunyamin Kaplan, Oguz G. Yildiz, Bulent Eser, Ismail Sari, Ramazan

Demir. Phase II study of Cisplatin-Etoposide (CE) combination

chemotherapy + low molecular weight heparin (LMWH) in small cell lung

cancer (SCLC). Annals of Oncology 2004, Suppl 3 (15):162;

B32. Ozlem Er , Debbie Frye, Kristine Broglio, Vicente Valero, Gabriel

N. Hortobagyi, Banu Arun. Clinical Course Of Breast Cancer Patients wıth

Liver Metastases Only Treated With Chemotherapy. Annals of Oncology

2004, Suppl 3 (15):42;

B33. M. Ozkan, I. Sari, I. Kocyigit, O. Er, B. Eser, Y. Ozkul, G. Gokoz,

M. Cetin, M. Altinbas. “Trombosis in Cancer Patients” (P1002), Journal of

trombosis and Haemostasis, 2005, Vol3 (Suppl 8);

B34. O. Er, M. Ozkan, S. Coskun, G. Dogu, M. Altinbas.

“Cisplatin+gemcitabine versus cisplatin+vinorelbine in patients with

stage IV non-small cell lung cancer (NSCLC): Results of single center

experience” (P481) Lung Cancer, 49 (Suppl 2), 243 (2005);

B35. I. Soyuer, S. Soyuer, K. Ucar, O. G. Yildiz, O. Orhan, M. Ozkan, O.

Er, M. Altinbas, B. Kaplan “Prognostic significance of CD9 and NF-kb in

gastric carcinoma patients treated with surgery and adjuvant

chemoradiotherapy” (P2-017) XXIII. World Congress of Pathology and

Laboratory Medicine 199 (2005);

B36. Coşkun HŞ, Yilmaz O, Alanoğlu G, Şahin M, Er Ö, Ergürhan İlhan

İ. Chemotherapy associated anemia in solid tumor patienst from

Anatolia. ASCO 41st Annual Meeting Proceedings. J Clinical Oncology

2005; 23: (16S): 729s, P: 8257;

B37. M Altinbas, AT Ersozlu, M Dikilitas, GG Dogu, M Ozkan, O Er. Early

osteoporosis risk in premenopausal women with breast cancer after

9

ovarian ablation. 31st ESMO Congess, Annals of Oncology 2006; 17: S9:

316;

B38. M Ozguroglu, T Evrensel, O Er, H Turna, T Yanmaz, O Yildiz, N

Mandel, S Serdengecti. Phase II trial of a combination of weekly

docetaxel and four-weekly carboplatin in the first line treatment of

advanced non-small cell lung cancer. 31st ESMO Congess, Annals of

Oncology 2006; 17: S9: 756P;

B39. M Ozkan, A Okur, M Dikilitas, E Mavili, O Er, GG Dogu, M Altinbas,

M Gulec. The effect of concurrent chemotherapy and low molecular

weight heparin (dalteparin) on tumor angiogenesis in patients with small

cell lung cancer: Radiologic evaluation-preliminary results. 31st ESMO

Congress, Annals of Oncology 2006; 17: S9: 811;

B40. G Demir, N Zengin, O Yildiz, G Dogusoy, F Aykan, O Er, A

Isikdogan, S Turhal, U Yilmaz, Suayib Yalcin. The role of lymph nodes on

disease free survival in operated gastric cancer (Turkish Oncology Group

Study). 31st ESMO Congress, Annals of Oncology 2006; 17: S9: 1100P;

B41. G Demir, N Zengin, O Yildiz, S Ozdamar, F Aykan, O Er, M Ilhan, S

Turhal, U Yilmaz, Suayib Yalcin. Clinical profile of gastric cancer in

Turkey: Factors effecting disease free survival and relapse (Turkish

Oncology Group Study). 31st ESMO Congress, Annals of Oncology 2006;

17: S9: 1139;

B42. M Ozkan, M Dikilitas, I Kocyigit, O Er, I Sari, GG Dogu, B Eser, Y

Ozkul, A Unal, M Altinbas. Thrombosis and cancer:Clinical, laboratuary

and genetic evaluation. 31st ESMO Congress, Annals of Oncology 2006;

17: S9: 1048P;

B43. O Er, M Inanc, M Ozkan, GG Dogu, M Dikilitas, A Ozturk.

Predicitive value of D-Dimer and LDH levels in response to chemoterapy

in metastatic colorectal cancer patients. Journal of Clinical Oncology,

2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No 18S,

2007:14568;

B44. B Yalcin, S Yalcin, A Buyukcelik, O Sencan, M Dogan, M Turk, F

Ozdemir, A Isikdogan, O Er, H Akbulut, F Icli. Opinions of the Turkish

population on cancer and being informed for the diagnosis of cancer: An

opinion survey. Journal of Clinical Oncology, 2007 ASCO Annual Meeting

Proceedings Part I. Vol 25, No 18S, 2007:19680;

B45. A Sevinc, C Camci, I Sari, ME Kalender, O Er, I Soyuer, M Dikilitas,

U Yilmaz, O Sagol, A Alacacioglu. Cyclooxygenase-2 expression in

gastrointestinal stromal tumors. J Clin Oncol 2008: 26 (May 20 Suppl;

abstr 15643);

B46. Agnieszka K. Witkiewicz, Thai H. Tran, Ozlem Er, Terry Hyslop,

Hallgeir Rui. Nuclear expression of transcription factors Stat5a and

Stat5b confers favorable prognosis in breast cancer. Proceedings of the

100th Annual Meeting of the American Association for Cancer Research;

2009 Apr 18-22; Denver, CO. Philadelphia (PA): AACR; 2009. Abstract

nr {5286};

ПОДРОБНО

Сервисы

Онкология
Онкология

клиники

Группа клиник «Acibadem»
Группа клиник «Acibadem»
Лечение в Турции
  • поделитесь:
  • Share
© 2018 HTICENTERS.COM